生物技术公司Celcuity Inc（纳斯达克股票代码：CELC）今日盘前股价大跌5.76%，引发市场关注。这一跌势与前一交易日的大幅上涨形成鲜明对比，可能反映了投资者的获利回吐行为。
根据交易数据，Celcuity在7月28日经历了惊人的167.18%的涨幅，股价报收于36.79美元。该股票在过去5个交易日内累计上涨171.71%，年初至今涨幅更是高达181.05%。如此迅猛的涨势可能引发了部分投资者选择在盘前交易中兑现收益。
值得注意的是，尽管出现盘前跌势，多家券商仍然看好Celcuity的前景。H.C. Wainwright将目标价从27美元上调至50美元，杰富瑞证券将目标价从33美元上调至54美元，而Needham更是将目标价从29美元大幅上调至74美元。这些积极的分析师评级可能会在常规交易时段为股价提供支撑。投资者应密切关注Celcuity的后续走势，权衡短期波动与长期发展前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.